Displaying 181 - 200 of 217
FTC, FDA Send Warning Letters to Seven Companies about Unsupported Claims that Products Can Treat or Prevent Coronavirus
Date
The Federal Trade Commission and U.S. Food and Drug Administration (FDA) have sent warning letters to seven companies allegedly selling unapproved products that may violate federal law by making...
Warning Letter to Quinessence Aromatherapy Ltd.
Date Sent
File
Quinessence Aromatherapy Ltd.
(205 KB)
Mar09
FDA / FTC Workshop on a Competitive Marketplace for Biosimilars
-
The Federal Trade Commission in collaboration with the Food and Drug Administration held a public workshop, "FDA/FTC Workshop on a Competitive Marketplace for Biosimilars." The purpose of the public...
Marketers of Pain Relief Device Settle FTC False Advertising Complaint
Date
Under a settlement with the Federal Trade Commission, the marketers of an electrical nerve stimulation device called Quell have agreed to pay at least $4 million and stop making deceptive claims that...
FTC, FDA to Hold Workshop on Promoting Competition in Markets for Biologics
Date
On March 9, 2020, the Federal Trade Commission and the Food and Drug Administration will co-sponsor a public workshop on promoting competition in biologics markets. The workshop will be held at the...
FTC, FDA Sign Joint Statement Promoting Competition in Markets for Biologics
Date
Federal Trade Commission Chairman Joseph J. Simons today joined Food and Drug Administration Commissioner Stephen Hahn in signing a joint statement promoting competition in biologics markets....
Joint FDA-FTC Statement Regarding Collaboration to Advance Competition in the Biologic Marketplace
Date
Matter Number
V190003
FTC and FDA Warn Florida Company Marketing CBD Products about Claims Related to Treating Autism, ADHD, Parkinson’s, Alzheimer’s, and Other Medical Conditions
Date
The Federal Trade Commission announced a joint warning letter issued with the U.S. Food and Drug Administration (FDA) to Rooted Apothecary, LLC for selling products containing cannabidiol (CBD) online...
Reckitt Benckiser Group plc to Pay $50 Million to Consumers, Settling FTC Charges that the Company Illegally Maintained a Monopoly over the Opioid Addiction Treatment Suboxone
Date
Reckitt Benckiser Group plc has agreed to pay $50 million to settle Federal Trade Commission charges that it violated the antitrust laws through a deceptive scheme to thwart lower-priced generic...
Displaying 181 - 200 of 217